Mark A. Velleca
PRESIDENT & CEO · Black Diamond Therapeutics, Inc.
Individual
- 2026
- Jan 23, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Mark A. Velleca's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Joaquin Duato - $66.84M in JNJ purchases and sales in the last 12 months
- Eric Venker - $65.62M in ROIV purchases and sales in the last 12 months
- EcoR1 Capital, LLC - $65.00M in TRAX purchases and sales in the last 12 months
- Forbion Growth Opportunities Fund III Cooperatief U.A. - $64.80M in BRVE purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $63.45M in SEPN purchases and sales in the last 12 months
- BVF PARTNERS L P - $62.96M in MLTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark A. Velleca?
Mark A. Velleca is a corporate insider, tracked as PRESIDENT & CEO of Black Diamond Therapeutics, Inc. (BDTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Mark A. Velleca last file a Form 4?
The only primary Form 4 on record is dated 23 January 2026.